PROREPAIR-A: Clinical and molecular characterization study of prostate cancer (PC) patients with and without previously known germline BRCA1/2 mutations.

被引：0
|
作者：
Lozano, Rebeca
Castro, Elena
Aragon, Isabel
Thorne, Heather
Lopez-Campos, Fernando
Sanz, Alejandro
Alonso, Concepcion
Anido, Urbano
Maria Jose, Juan
Gutierrez Pecharroman, Ana
Ramirez-Backhaus, Miguel
Balmana Gelpi, Judith
Chirivella, Isabel
Llort, Gemma
Romero-Laorden, Nuria
Arevalo, Sara
Rubio, Jose
Di Domenico, Tomas
Kaur Sandhu, Shahneen
Olmos, David
机构：
[1] Spanish Natl Canc Res Ctr, Prostate Canc Clin Res Unit, Madrid, Spain
[2] Hosp Virgen Victoria & Reg Malaga, Inst Invest Biomed Malaga, Malaga, Spain
[3] Inst Biomed Res Malaga IBIMA, Genitourinary Canc Traslat Res Unit, Malaga, Spain
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Ramon Y Cajal Univ Hosp, Radiat Oncol Dept, Madrid, Spain
[6] CNIO, Spanish Natl Canc Res Ctr, Madrid, Spain
[7] Hosp Univ Princesa, Madrid, Spain
[8] Complejo Hosp Univ Santiago de Compostela, Santiado De Complostela, Spain
[9] Inst Valenciano Oncol, Valencia, Spain
[10] Hosp Univ Mostoles, Madrid, Spain
[11] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
[12] Hosp Clin Univ, Dept Med Oncol, INCLIVA, Valencia, Spain
[13] Sanitaria Univ Parc Tauli, Hereditary Canc Unit, Sabadell, Spain
[14] Sanitaria Univ Parc Tauli, Med Oncol Dept, Sabadell, Spain
[15] Hosp Donostia, Guipuzcoa, Spain
[16] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5511
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study
    Lozano Mejorada, R.
    Castro Marcos, E.
    Aragon, I. M.
    Thorne, H.
    Lopez Campos, F.
    Sanz, A.
    Alonso, C.
    Anido, U.
    Juan Fita, M. J.
    Gutierrez Pecharroman, A. M.
    Ramirez-Backhaus, M.
    Balmana, J.
    Chirivella Gonzalez, I.
    Llort, G.
    Romero Laorden, N.
    Arevalo Lobera, S.
    Rubio Briones, J.
    Pritchard, C. C.
    Sandhu, S.
    Olmos Hidalgo, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S509 - S510
  • [2] Germline testing in community oncology patients with somatic BRCA1/2 mutations.
    Principe, Kate
    Nichols, Trisha
    Patel, Gayle
    Bunnell, Ann
    Fisher, Camille
    Lord, Katharine
    Carlisle, Steven
    Torres, Vanessa
    Wilfong, Lalan S.
    Kodali, Dhatri
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
    Pawel Rajwa
    Fahad Quhal
    Benjamin Pradere
    Giorgio Gandaglia
    Guillaume Ploussard
    Michael S. Leapman
    John L. Gore
    Andrzej Paradysz
    Derya Tilki
    Axel S. Merseburger
    Todd M. Morgan
    Alberto Briganti
    Ganesh S. Palapattu
    Shahrokh F. Shariat
    Nature Reviews Urology, 2023, 20 : 205 - 216
  • [4] Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
    Rajwa, Pawel
    Quhal, Fahad
    Pradere, Benjamin
    Gandaglia, Giorgio
    Ploussard, Guillaume
    Leapman, Michael S.
    Gore, John L.
    Paradysz, Andrzej
    Tilki, Derya
    Merseburger, Axel S.
    Morgan, Todd M.
    Briganti, Alberto
    Palapattu, Ganesh S.
    Shariat, Shahrokh F.
    NATURE REVIEWS UROLOGY, 2023, 20 (04) : 205 - 216
  • [5] EXCELLENT EMBRYO DEVELOPMENT AND IVF OUTCOMES FOR PATIENTS WITH GERMLINE BRCA1 OR BRCA2 MUTATIONS.
    King, A.
    Hornberger, K. L.
    Young, D. O.
    Klepacka, D.
    Schoolcraft, W. B.
    Katz-Jaffe, M.
    FERTILITY AND STERILITY, 2016, 106 (03) : E373 - E374
  • [6] BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients
    Cecener, Gulsah
    Egeli, Unal
    Tunca, Berrin
    Erturk, Elif
    Ak, Secil
    Gokgoz, Sehsuvar
    Tasdelen, Ismet
    Tezcan, Gulcin
    Demirdogen, Elif
    Bayram, Nuran
    Avci, Nilufer
    Evrensel, Turkkan
    CANCER INVESTIGATION, 2014, 32 (08) : 375 - 387
  • [7] Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients
    Manguoglu, Esra
    Guran, Sefik
    Yamac, Deniz
    Colak, Taner
    Simsek, Mehmet
    Baykara, Mehmet
    Akaydin, Mustafa
    Luleci, Guven
    CANCER GENETICS AND CYTOGENETICS, 2010, 203 (02) : 230 - 237
  • [8] Characteristics of colorectal cancer (CRC) patients with BRCA1 and BRCA2 mutations.
    Naseem, Madiha
    Xiu, Joanne
    Salem, Mohamed E.
    Goldberg, Richard M.
    Vanderwalde, Ari M.
    Grothey, Axel
    Philip, Philip Agop
    Seeber, Andreas
    Puccini, Alberto
    Tokunaga, Ryuma
    Battaglin, Francesca
    Berger, Martin D.
    Barzi, Afsaneh
    Hanna, Diana L.
    Zhang, Wu
    Hwang, Jimmy J.
    Shields, Anthony Frank
    Marshall, John
    Korn, Wolfgang Michael
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [9] Clinical features and prognosis of Turkish epithelial ovarian cancer patients with BRCA1 and BRCA2 mutations.
    Saip, P
    Yazici, H
    Karagol, H
    Bengisu, E
    Topuz, E
    Dalay, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 482S - 482S
  • [10] Identification of breast-ovarian cancer families without BRCA1 or BRCA2 mutations.
    Unger, M
    Nathanson, KL
    Antin-Ozerkis, D
    Martin, AM
    Shih, HA
    Calzone, KA
    Ward, T
    Mazoyer, S
    Rebbeck, T
    Weber, BL
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A328 - A328
12345